1. Home
  2. Clinical Topics
  3. FDA drug approvals
Clinical TopicsDrugs and DevicesWeb Exclusives

FDA drug approvals

Share

On Jan. 28, the Food and Drug Administration (FDA) approved:

  • Zepatier (elbasvir and grazoprevir) with or without ribavirin for the treatment of chronic hepatitis C virus (HCV) genotypes 1 and 4 infections in adult patients. Read more.
  • Halaven (eribulin mesylate) for the treatment of liposarcoma that is unresectable or metastatic. Treatment is approved for patients who received prior chemotherapy that contained an anthracycline drug. Read more.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Poll

Recent Posts